Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Daito Pharmaceutical Co., Ltd. ( (JP:4577) ) has issued an update.
Daito Pharmaceutical Co., Ltd. announced the repurchase of 64,500 shares of its own common stock, amounting to 132,139,100 yen, as part of a previously approved buyback program. This strategic move underscores the company’s commitment to enhancing shareholder value and indicates a positive outlook on its financial position.
More about Daito Pharmaceutical Co., Ltd.
Daito Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, primarily engaging in the development and sale of pharmaceutical products. It is listed on the Prime Market of the Tokyo Stock Exchange, implying a focus on high standards of corporate governance and operational efficiency.
YTD Price Performance: -0.67%
Average Trading Volume: 31,467
Technical Sentiment Consensus Rating: Buy
Current Market Cap: Yen31.85B
See more data about 4577 stock on TipRanks’ Stock Analysis page.